131 related articles for article (PubMed ID: 21390220)
1. Prostate cancer postoperative nomogram scores and obesity.
Major JM; Klonoff-Cohen HS; Pierce JP; Slymen DJ; Saltzstein SL; Macera CA; Mercola D; Kattan MW
PLoS One; 2011 Feb; 6(2):e17382. PubMed ID: 21390220
[TBL] [Abstract][Full Text] [Related]
2. Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy.
Rouprêt M; Hupertan V; Comperat E; Drouin SJ; Phé V; Xylinas E; Demanse D; Sibony M; Richard F; Cussenot O
BJU Int; 2009 Sep; 104(6):813-7; discussion 817-8. PubMed ID: 19254280
[TBL] [Abstract][Full Text] [Related]
3. Performance of prostate cancer recurrence nomograms by obesity status: a retrospective analysis of a radical prostatectomy cohort.
Zeigler-Johnson C; Hudson A; Glanz K; Spangler E; Morales KH
BMC Cancer; 2018 Nov; 18(1):1061. PubMed ID: 30390642
[TBL] [Abstract][Full Text] [Related]
4. A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men.
Graefen M; Karakiewicz PI; Cagiannos I; Hammerer PG; Haese A; Palisaar J; Fernandez S; Noldus J; Erbersdobler A; Huland H; Scardino PT; Kattan MW
Urol Oncol; 2002; 7(4):141-6. PubMed ID: 12474529
[TBL] [Abstract][Full Text] [Related]
5. Validation of two preoperative Kattan nomograms predicting recurrence after radical prostatectomy for localized prostate cancer in Turkey: a multicenter study of the Uro-oncology Society.
Eskicorapci SY; Türkeri L; Karabulut E; Cal C; Akpinar H; Baltaci S; Baykal K; ; Kattan MW; Ozen H
Urology; 2009 Dec; 74(6):1289-95. PubMed ID: 19589584
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.
Tamblyn DJ; Chopra S; Yu C; Kattan MW; Pinnock C; Kopsaftis T
BJU Int; 2011 Nov; 108 Suppl 2():51-6. PubMed ID: 22085129
[TBL] [Abstract][Full Text] [Related]
7. Stage migration in localized prostate cancer has no effect on the post-radical prostatectomy Kattan nomogram.
Thanigasalam R; Rasiah KK; Stricker PD; Haynes AM; Sutherland SI; Sutherland RL; Henshall SM; Horvath LG
BJU Int; 2010 Mar; 105(5):642-7. PubMed ID: 19751263
[TBL] [Abstract][Full Text] [Related]
8. Combined multiple clinical characteristics for prediction of discordance in grade and stage in prostate cancer patients undergoing systematic biopsy and radical prostatectomy.
Liu H; Tang K; Xia D; Peng E; Wang L; Chen Z
Pathol Res Pract; 2020 Nov; 216(11):153235. PubMed ID: 33035728
[TBL] [Abstract][Full Text] [Related]
9. Predicting pathological outcomes in patients undergoing robot-assisted radical prostatectomy for high-risk prostate cancer: a preoperative nomogram.
Abdollah F; Klett DE; Sood A; Sammon JD; Pucheril D; Dalela D; Diaz M; Peabody JO; Trinh QD; Menon M
BJU Int; 2015 Nov; 116(5):703-12. PubMed ID: 25413443
[TBL] [Abstract][Full Text] [Related]
10. Predictive models and risk of biopsy progression in active surveillance patients.
Iremashvili V; Manoharan M; Kava BR; Parekh DJ; Punnen S
Urol Oncol; 2017 Feb; 35(2):37.e1-37.e8. PubMed ID: 27692836
[TBL] [Abstract][Full Text] [Related]
11. How often do available preoperative risk factors accurately predict the risk assessed after surgery for localized prostate cancer?
Laudano MA; Lambert SM; Masson P; McCann TR; Desai M; Benson MC; McKiernan JM
BJU Int; 2009 Feb; 103(3):317-20. PubMed ID: 18778341
[TBL] [Abstract][Full Text] [Related]
12. Prediction of pathological stage at radical prostatectomy: do commonly used prostate cancer nomograms apply to men from Far North Queensland?
Nesbitt AL; Kapoor J; Piesse C; Evans G; Antoniou S; Smith P; Pridgeon SW
ANZ J Surg; 2019 Jan; 89(1-2):111-114. PubMed ID: 30560567
[TBL] [Abstract][Full Text] [Related]
13. Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer.
Wang SY; Cowan JE; Cary KC; Chan JM; Carroll PR; Cooperberg MR
BJU Int; 2014 Dec; 114(6b):E18-E24. PubMed ID: 24712895
[TBL] [Abstract][Full Text] [Related]
14. Genetic predisposition to early recurrence in clinically localized prostate cancer.
Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a preoperative nomogram for predicting survival of patients with locally advanced prostate cancer after radical prostatectomy.
Zhou X; Ning Q; Jin K; Zhang T; Ma X
BMC Cancer; 2020 Feb; 20(1):97. PubMed ID: 32019501
[TBL] [Abstract][Full Text] [Related]
16. The CPC Risk Calculator: A New App to Predict Prostate-specific Antigen Recurrence During Follow-up After Radical Prostatectomy.
Røder MA; Berg KD; Loft MD; Thomsen FB; Ferrari M; Kurbegovic S; Rytgaard HC; Gruschy L; Brasso K; Gerds TA; Kjær A; Brooks JD; Iversen P
Eur Urol Focus; 2018 Apr; 4(3):360-368. PubMed ID: 28753827
[TBL] [Abstract][Full Text] [Related]
17. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
[TBL] [Abstract][Full Text] [Related]
18. Postoperative prostate-specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databases.
Moreira DM; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Sun LL; Moul JW; Freedland SJ
Int J Urol; 2010 Nov; 17(11):914-22. PubMed ID: 20880361
[TBL] [Abstract][Full Text] [Related]
19. Optimum Tools for Predicting Clinical Outcomes in Prostate Cancer Patients Undergoing Radical Prostatectomy: A Systematic Review of Prognostic Accuracy and Validity.
Campbell JM; Raymond E; O'Callaghan ME; Vincent AD; Beckmann KR; Roder D; Evans S; McNeil J; Millar J; Zalcberg J; Borg M; Moretti KL
Clin Genitourin Cancer; 2017 Oct; 15(5):e827-e834. PubMed ID: 28666689
[TBL] [Abstract][Full Text] [Related]
20. Implementing the use of nomograms by choosing threshold points in predictive models: 2012 updated Partin Tables vs a European predictive nomogram for organ-confined disease in prostate cancer.
Borque Á; Rubio-Briones J; Esteban LM; Sanz G; Domínguez-Escrig J; Ramírez-Backhaus M; Calatrava A; Solsona E
BJU Int; 2014 Jun; 113(6):878-86. PubMed ID: 24529282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
